How good are the crystallisation methods for co-crystals? A comparative study of piroxicam

被引:86
作者
Fucke, Katharina [1 ]
Myz, Svetlana A. [2 ,3 ]
Shakhtshneider, Tatyana P. [2 ,3 ]
Boldyreva, Elena V. [2 ,3 ]
Griesser, Ulrich J. [4 ]
机构
[1] Univ Durham, Dept Chem, Durham DH1 3LE, England
[2] REC 008 Novosibirsk State Univ, Novosibirsk 630090, Russia
[3] Inst Solid State Chem & Mechanochem SB RAS, Novosibirsk 630128, Russia
[4] Univ Innsbruck, Dept Pharm, A-6020 Innsbruck, Austria
基金
俄罗斯基础研究基金会;
关键词
PHARMACEUTICAL COCRYSTALS; SOLUBILITY ADVANTAGE; SOLID DISPERSION; DISSOLUTION RATE; SUPRAMOLECULAR SYNTHONS; PHASE-TRANSFORMATIONS; ENHANCED SOLUBILITY; DICARBOXYLIC-ACIDS; PICRIC ACID; DRUG;
D O I
10.1039/c2nj40093f
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Co-crystallisation of two components into one crystal form can enhance the solid-state properties of drug compounds. A plethora of crystallisation methods has been applied to co-crystallisation and the reported study compares the three most common ones (crystallisation from the melt, from solution and solvent-drop grinding) with respect to their applicability and necessity for a co-crystal screening. Piroxicam, a non-steroidal anti-inflammatory drug, was chosen as a model system and submitted to an extensive co-crystal screening using twenty different acids as co-crystal formers, six crystallisation techniques and five solvents. A total of 46 co-crystal forms were obtained, 38 of which are novel. Solvent-drop grinding showed the highest absolute number of experiments resulting in co-crystals, while crystallisation from the melt yielded the highest number of co-crystal formation when crystalline material was obtained. Evaporation resulted in a high number of crystalline products but many of those were binary and ternary mixtures of crystal forms. Cooling and precipitation techniques gave only poor results. Acetone and THF showed the highest number of crystalline products while chloroform gave the highest relative yield of co-crystals. Ethanol and acetonitrile showed extensive hydrate formation. No influence of the co-crystal former on the co-crystal formation could be detected.
引用
收藏
页码:1969 / 1977
页数:9
相关论文
共 84 条
[1]   Mapping out the synthetic landscape for re-crystallization, co-crystallization and salt formation [J].
Aakeroey, Christer B. ;
Rajbanshi, Arbin ;
Li, Z. Jane ;
Desper, John .
CRYSTENGCOMM, 2010, 12 (12) :4231-4239
[2]   Building co-crystals with molecular sense and supramolecular sensibility [J].
Aakeröy, CB ;
Salmon, DJ .
CRYSTENGCOMM, 2005, 7 :439-448
[3]   Cocrystal or salt:: Does it really matter? [J].
Aakeroy, Christer B. ;
Fasulo, Meg E. ;
Desper, John .
MOLECULAR PHARMACEUTICS, 2007, 4 (03) :317-322
[4]   The Cambridge Structural Database: a quarter of a million crystal structures and rising [J].
Allen, FH .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 2002, 58 (3 PART 1) :380-388
[5]   Crystal engineering of the composition of pharmaceutical phases.: Do pharmaceutical co-crystals represent a new path to improved medicines? [J].
Almarsson, Ö ;
Zaworotko, MJ .
CHEMICAL COMMUNICATIONS, 2004, (17) :1889-1896
[6]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[7]  
[Anonymous], 2000, FDA GUIDANCE IND WAI
[8]   Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals [J].
Babu, N. Jagadeesh ;
Nangia, Ashwini .
CRYSTAL GROWTH & DESIGN, 2011, 11 (07) :2662-2679
[9]   Indomethacin-saccharin cocrystal:: Design, synthesis and preliminary pharmaceutical characterization [J].
Basavoju, Srinivas ;
Bostrom, Dan ;
Velaga, Sitaram P. .
PHARMACEUTICAL RESEARCH, 2008, 25 (03) :530-541
[10]   Applying hot-stage microscopy to co-crystal screening: A study of nicotinamide with seven active pharmaceutical ingredients [J].
Berry, David J. ;
Seaton, Colin C. ;
Clegg, William ;
Harrington, Ross W. ;
Coles, Simon J. ;
Horton, Peter N. ;
Hursthouse, Michael B. ;
Storey, Richard ;
Jones, William ;
Friscic, Tomislav ;
Blagden, Nicholas .
CRYSTAL GROWTH & DESIGN, 2008, 8 (05) :1697-1712